INDIANAPOLIS, June 28, 2018 /PRNewswire/ — Eli Lilly and Company(NYSE: LLY) announced today that Taltz® (ixekizumab) met the primary and major secondary endpoints in COAST-W, a Phase 3 study evaluating the safety and efficacy of Taltz for the treatment of Ankylosing Spondylitis (AS), also known as radiographic axial spondyloarthritis (r-axSpA). This is the first …
Tag Archives: Taltz
June, 2018
December, 2017
-
4 December
Lilly’s Taltz Receives FDA Approval for the Treatment of Active Psoriatic Arthritis
INDIANAPOLIS, Dec. 1, 2017 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Taltz® (ixekizumab) injection 80 mg/mL for the treatment of adults with active psoriatic arthritis (PsA).1 Taltz was first approved by the FDA in March 2016 for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for …
June, 2017
-
16 June
Lilly’s Taltz Significantly Improves Disease Signs and Symptoms in Psoriatic Arthritis Patients with Inadequate Response or Intolerance to TNF Inhibitors
altz INDIANAPOLIS, June 15, 2017 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that patients with active psoriatic arthritis (PsA) who had inadequate response to one or two TNF inhibitors or were intolerant of TNF inhibitors treated with Taltz® (ixekizumab) achieved significant improvement in signs and symptoms of …
August, 2016
-
17 August
A Tricky Time
Psoriasis comes in several forms, with plaque psoriasis being the most common. Earlier this year, a new medication – Taltz® (ixekizumab) – gained FDA approval as another option for treating moderate-to-severe cases of plaque psoriasis, in which thick, red areas on the skin become flaky with silver-white scales. Taltz, an …
March, 2016
-
22 March
FDA Approves Lilly’s Taltz for Treatment of Psoriasis
The U.S. Food and Drug Administration today approved Taltz (ixekizumab) to treat adults with moderate-to-severe plaque psoriasis. Psoriasis is a skin condition that causes patches of skin redness and flaking. Psoriasis is an autoimmune disorder that occurs more commonly in patients with a family history of the disease, and most …